Barrett & Company’s iShares Biotechnology ETF IBB Stock Holding History

Barrett & Company’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$119K	Hold	566	–	–	0.03%	201
2026 Q2	$108K	Hold	566	–	–	0.03%	235
2026 Q1	$95.6K	Hold	566	–	–	0.03%	215
2025 Q4	$95.5K	Hold	566	–	–	0.03%	214
2025 Q3	$81.7K	Sell	566 -38	-6%	-$5.19K	0.03%	233
2025 Q2	$76.4K	Hold	604	–	–	0.03%	244
2025 Q1	$77.3K	Hold	604	–	–	0.03%	221
2024 Q4	$79.9K	Buy	604 +16	+3%	+$2.25K	0.03%	222
2024 Q3	$85.7K	Hold	588	–	–	0.04%	214
2024 Q2	$80.7K	Hold	588	–	–	0.04%	215
2024 Q1	$80.7K	Hold	588	–	–	0.04%	222
2023 Q4	$79.9K	Hold	588	–	–	0.04%	213
2023 Q3	$71.9K	Hold	588	–	–	0.04%	214
2023 Q2	$74.7K	Hold	588	–	–	0.04%	218
2023 Q1	$76K	Hold	588	–	–	0.05%	210
2022 Q4	$77.2K	Hold	588	–	–	0.05%	194
2022 Q3	$77.2K	Buy	+588	New	+$73K	0.05%	194

Other funds holding IBB

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

WestEnd Advisors Charlotte, North Carolina $4.53B AUM 12.98% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Barrett & Company's IBB Position: Q3 2026 in Review

Barrett & Company held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 566 shares worth $119K. The position accounts for 0.03% of the portfolio, ranked #201.

Barrett & Company first reported a position in IBB in Q3 2022 and has held it in 17 quarters since. 700 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

Barrett & Company held 566 shares of iShares Biotechnology ETF worth $119K as of Q3 2026.
Barrett & Company left its iShares Biotechnology ETF share count unchanged in Q3 2026.
iShares Biotechnology ETF made up 0.03% of Barrett & Company's portfolio in Q3 2026, its #201 holding.
Barrett & Company first reported a position in iShares Biotechnology ETF in Q3 2022 and has held it in 17 quarters since.
700 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Barrett & Company's 13F filing for Q3 2026, filed 22 Oct 2026.